For instance, The water-soluble polar components of the Dahuang Zhechong pill (DHZCP) inhibit Treg differentiation and enhance the tumor-killing ability of CD8+ T cells by reducing hepatoma cell metabolism, lowering TME acidity, and depleting glutamine. This evidence concerns the gene CD8A and hepatocellular carcinoma.